Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q3 2024 · 10-Q
Revenue$686.85M$686.85M−73.5% vs Q3 2023 Net Income-$12.77M-$12.77MN/M vs Q3 2023 EPS Diluted-$0.16-$0.16N/M vs Q3 2023 Gross Profit$559,706,000+3.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Operating Cash Flowderived$27,307,000−82.7% Free Cash Flowderived-$30,345,000N/M Margins · derivedGross margin81.5%+60.7 pt vs Q3 2023
Operating margin4.5%+3.6 pt vs Q3 2023
Net margin-1.9%−1.6 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 4, 2024 · 35 d after period end